Oral GLP-1 Agonist Orforglipron Shows Promise for Type 2 Diabetes and Weight Management

Source: Pharmacy Times articles

Orforglipron showed promising results in managing type 2 diabetes, offering a potential oral alternative to injectable treatments.
Read More